By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Pozen, Inc. 

6330 Quadrangle Drive, Suite 240

Chapel Hill  North Carolina  27514  U.S.A.
Phone: 919-490-0012 Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Pozen, Inc. (POZN)’s YOSPRALA™ Receives Complete Response Letter From The FDA 12/17/2014 5:58:52 AM
Pozen, Inc. (POZN) Crashes As FDA Rejects Two Forms Of Its Lead Drug Yosprala 12/17/2014 5:57:38 AM
Pozen, Inc. (POZN) And Sanofi US (SNY) Mutually Agree To Terminate U.S. Partnership For PA8140/PA32540 12/1/2014 12:18:45 PM
Sanofi (SAN.PA), Pozen, Inc. (POZN) Terminate U.S. License Agreement For Gastric Ulcer Drugs 12/1/2014 5:49:54 AM
Pozen, Inc. (POZN) Reports Third Quarter 2014 Results 11/6/2014 11:48:37 AM
Pozen, Inc. (POZN) Announces November 6th Webcast Of Third Quarter 2014 Results 10/30/2014 10:22:24 AM
Pozen, Inc. (POZN) Announces Receipt Of Three Patents From The United States Patent And Trademark Office 10/23/2014 9:38:28 AM
Pozen, Inc. (POZN) Takes Another Step To No Longer Being A Drug Developer; Shrinks Workforce 8/22/2014 6:22:49 AM
Pozen, Inc. (POZN) Announces U.S. Rights For TREXIMET® Have Been Acquired By Pernix Therapeutics, Inc. (PTX) 8/20/2014 8:32:41 AM
Pozen, Inc. (POZN) Announces August 7th Webcast Of Second Quarter 2014 Results 7/25/2014 9:30:18 AM
12345678910...
//-->